PatrickA.Zweidler-MckayMDMD/PhD
Pediatric Hematology & Oncology • Houston, TXSection Chief for Pediatric Leukemia & Lymphoma
Dr. Zweidler-Mckay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
UT M. D. Anderson Cancer Center
1515 Holcombe Blvd, Unit 853
Houston, TX 77030Phone+1 713-563-5395- Is this information wrong?
Education & Training
Children's Hospital of PhiladelphiaResearch Fellow, Pediatric Hematology & Oncology, 2003 - 2005- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 2000 - 2003
Massachusetts General HospitalResidency, Pediatrics, 1997 - 2000
Massachusetts General HospitalResident, 1997 - 2000
Temple University School of MedicineMD/PhD, Molecular Biology & Genetics, 1989 - 1997
Lewis Katz School of Medicine at Temple UniversityClass of 1997
Certifications & Licensure
TX State Medical License 2006 - 2018
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Start of enrollment: 2010 Mar 01
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
- Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Start of enrollment: 2011 Sep 28
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsCorrection: Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932.Reuven J Schore, Anne L Angiolillo, John A Kairalla, Meenakshi Devidas, Karen R Rabin, Patrick Zweidler-McKay, Michael J Borowitz, Brent Wood, Andrew J Carroll, Nyla A...> ;Leukemia. 2023 Jun 1
- 3 citationsOutstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932.Reuven J Schore, Anne L Angiolillo, John A Kairalla, Meenakshi Devidas, Karen R Rabin, Patrick Zweidler-McKay, Michael J Borowitz, Brent Wood, Andrew J Carroll, Nyla A...> ;Leukemia. 2023 Jun 1
- 17 citationsRacial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia: secondary analyses of eight Children's Oncology Group cohort trials.Sumit Gupta, Yunfeng Dai, Zhiguo Chen, Lena E Winestone, David T Teachey, Kira Bona, Richard Aplenc, Karen R Rabin, Patrick Zweidler-McKay, Andrew J Carroll, Nyla A He...> ;The Lancet. Haematology. 2023 Feb 1
- Join now to see all
Abstracts/Posters
- The Genomic Landscape of Childhood Acute Lymphoblastic LeukemiaPatrick A. Zweidler-McKay, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- A Phase I Study of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate, in Patients with Relapsed/Refractory Acute Myeloid Leukemia, Blastic Plasmacytoid Dendriti...Patrick A. Zweidler-McKay, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic ...Patrick A. Zweidler-McKay, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Maturing Clinical Profile of IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- A Phase I, First-in-Human Study Evaluating the Safety and Preliminary Antileukemia Activity of IMGN632, a Novel CD123-Targeting Antibody-Drug Conjugate, in Patients wi...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Triple Intrathecal Therapy (Methotrexate/Hydrocortisone/Cytarabine) Does Not Improve Disease-Free Survival Versus Intrathecal Methotrexate Alone in Children with High ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Press Mentions
Novel Subtypes in B Progenitor Acute Lymphoblastic LeukemiaDecember 12th, 2018
MD Anderson Researcher to Receive Grant for Childhood Cancer Research in Handprint CeremonyFebruary 12th, 2016
Grant Support
- HES1 Mediates Cell-Specific Consequences Of Notch Signaling In AllNational Cancer Institute2010–2012
- Notch In NeuroblastomaNational Cancer Institute2010–2011
- Notch-Mediated Apoptosis In Human B Cell MalignanciesNational Cancer Institute2005–2008
- Notch-Mediated Apoptosis In Human B Cell MalignanciesNational Cancer Institute2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
